National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 54237 [2011-22213]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 169 / Wednesday, August 31, 2011 / Notices
related to important state and local
government, stakeholder association,
and interest group activities;
coordinating Agency cross-Bureau
cooperative agreements and activities
with organizations such as the National
Governors Association, National
Conference of State Legislature,
Association of State and Territorial
Health Officials, National Association of
Counties, and National Association of
County and City Health Officials;
interacting with various commissions
such as the Delta Regional Authority,
Appalachian Regional Commission, and
on the Denali Commission; and serving
as the primary liaison to Department
intergovernmental staff; and (9) serves
as the coordinator for General
Accounting Office reports on HRSA
programs and activities.
Office of Research and Evaluation
(RA56)
(1) Serves as the principal source of
leadership and advice on program
information and research; (2) analyzes
and coordinates the Agency’s need for
information and data for use in the
management and direction of Agency
programs; (3) manages an Agency-wide
information and data group as well as
an Agency-wide research group; (4)
maintains an inventory of HRSA
databases; (5) provides technical
assistance to HRSA staff in database
development, maintenance, analysis,
and distribution; (6) promotes the
availability of HRSA data through Web
sites and other online applications; (7)
conducts, oversees, and fosters high
quality research across HRSA
programmatic interests; (8) develops an
annual research agenda for the Agency;
(9) conducts, leads, and/or participates
with HRSA staff in the development of
research and demonstration projects;
(10) coordinates HRSA participation in
institutional review boards and the
protection of human subjects; (11)
conducts, guides, and/or participates in
major program evaluation efforts and
prepares reports on HRSA program
efficiencies; and (12) manages HRSA
activity related to the Paperwork
Reduction Act, and other OMB policies.
jlentini on DSK4TPTVN1PROD with NOTICES
Section RA5–30, Delegations of
Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
VerDate Mar<15>2010
16:51 Aug 30, 2011
Jkt 223001
Dated: August 19, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011–22261 Filed 8–30–11; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
54237
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Dated: August 23, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2011–22213 Filed 8–30–11; 8:45 am]
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: October 13–14, 2011.
Time: October 13, 2011, 8:30 a.m. to 3:05
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 2C116, Bethesda, MD 20892.
Time: October 14, 2011, 8:30 a.m. to 2:40
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 2C116, Bethesda, MD 20892.
Contact Person: James E. Balow, MD,
Clinical Director, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Building 10,
Room 9N222, Bethesda, MD 20892–1818,
301–496–4181, jimb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel,
SPF Colonies.
Date: September 22, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Carol Lambert, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., Dem. 1, Room 1076,
Bethesda, MD 20892, 301–435–0814,
lambert@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: October 25, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, National Institutes
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 76, Number 169 (Wednesday, August 31, 2011)]
[Notices]
[Page 54237]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22213]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: October 13-14, 2011.
Time: October 13, 2011, 8:30 a.m. to 3:05 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Conference Room 2C116, Bethesda, MD 20892.
Time: October 14, 2011, 8:30 a.m. to 2:40 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 10 Center
Drive, Conference Room 2C116, Bethesda, MD 20892.
Contact Person: James E. Balow, MD, Clinical Director, National
Institute of Diabetes and Digestive and Kidney Diseases, National
Institutes of Health, Building 10, Room 9N222, Bethesda, MD 20892-
1818, 301-496-4181, jimb@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 23, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-22213 Filed 8-30-11; 8:45 am]
BILLING CODE 4140-01-P
